Here are five key notes:
1. Analysts have a one-year price target of $21 on Surgery Partners’ shares.
2. On Nov. 15, Zacks analysts downgraded Surgery Partners’ shares from a “buy” to a “hold” rating.
3. Surgery Partners has a one-year high of $22.32 and a one-year low of $11.76.
4. The company has a 50-day moving average of $18.13 and 200-day moving average of $17.28.
5. The market cap is $835.53 million.
More articles on surgery centers:
10 largest freestanding surgery centers: SK&A
Sparrow Health unveils $20M endoscopy and radiology center: 4 things to know
KeyCorp increases Surgery Partners’ yearly EPS estimate: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.